MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

Online Sports Betting Legalization and Behavioral Health Care Use

MedXY Editorial Team•Oct 20, 2026•news
behavioral healthoutpatient caremental healthonline sports bettingsubstance use disorderprescription medication

Introduction

The legalization of online sports betting in the United States has grown rapidly over the past several years, expanding from just one state in 2018 to over 30 states by 2023. While this expansion offers recreational and economic benefits, it also raises public health concerns due to the well-documented behavioral health risks associated with gambling, such as depression, anxiety, and substance use disorders (SUD). Understanding how legalization impacts mental health and related treatment is therefore critical to informing policy and healthcare responses.

Objective

This study aimed to evaluate the association between the legalization of online sports betting and the use of behavioral health treatment for mental health conditions and substance use disorders among people with employer-sponsored health insurance.

Study Design and Population

Researchers conducted a quasi-experimental staggered difference-in-differences analysis using health insurance claims data collected from January 2016 through December 2023. The study focused on adults aged 18 to 64 living in states that legalized online sports betting between 2018 and 2022, compared to those in states without such legalization by the end of 2023. The dataset was a large national convenience sample of individuals with employer-sponsored health coverage.

Exposure and Outcomes

The key exposure was the state-level legalization of online sports betting. Primary outcomes measured at the state-year level included:

  • Proportion of enrollees with one or more filled prescriptions for antidepressants, antianxiety medications, or medications to treat substance use disorders.

  • Proportion of enrollees with one or more outpatient, emergency department, or inpatient visits diagnosing depression, anxiety, or substance use disorders.

All estimates were weighted by the number of enrollees in the state to reflect population-level effects.

Results

The study analyzed data from over 61.9 million enrollee-years, with women constituting 52% of the sample. The average age was 41.9 years.

Key findings include:

  • Increased Use of Mental Health Medications: Following legalization, the probability of antidepressant prescriptions increased by 0.57 percentage points among men and 1.08 percentage points among women. Similarly, antianxiety medication use rose by 0.32 percentage points for men and 0.64 percentage points for women.

  • No Significant Change in Substance Use Disorder Medication Use: There was no detectable increase in prescriptions for medications targeting SUD after legalization.

  • Increased Outpatient Diagnoses: The probability of receiving an outpatient diagnosis for depression increased by 0.34 percentage points in men and 0.57 percentage points in women. Anxiety diagnoses rose by 0.67 percentage points among men and 1.15 percentage points among women.

  • No Changes in Emergency or Inpatient Behavioral Health Diagnoses: Legalization was not associated with increased behavioral health diagnoses in emergency department or inpatient settings.

Interpretation and Implications

These results suggest that legalizing online sports betting correlates with greater outpatient engagement and prescription treatment for depression and anxiety among adults with employer-sponsored health insurance. The absence of increased SUD medication use or hospital-based behavioral diagnoses might reflect either lower impact on substance use or possibly barriers to diagnosing and treating these disorders in higher-acuity settings.

It is plausible that increased betting availability and accessibility contribute to heightened stress, anxiety, or depressive symptoms, prompting more individuals to seek outpatient care. Alternatively, increased awareness and screening in outpatient settings following legalization might drive these findings.

Limitations

The study design cannot definitively establish causation, and findings are specific to insured populations, potentially limiting generalizability to those uninsured or with different insurance types. Additionally, claims data lack information on gambling behaviors directly, so the mechanism linking legalization to increased treatment remains inferred rather than directly observed.

Conclusions

The legalization of online sports betting is associated with increased utilization of outpatient mental health services and prescriptions for antidepressants and antianxiety medications among employed adults with health insurance. These findings highlight the need for proactive public health measures, including prevention programs, screening efforts, and accessible treatment options to mitigate potential adverse health consequences related to online sports betting. Policymakers and healthcare providers should consider integrating behavioral health services into broader gambling regulation strategies to support affected individuals effectively.

Reference

Westermeyer B, Eisenberg MD, Meiselbach MK. Online Sports Betting Legalization and Behavioral Health Care Use. JAMA Psychiatry. 2026 Oct 14:e263175. doi: 10.1001/jamapsychiatry.2026.3175. Epub ahead of print. PMID: 42873510; PMCID: PMC13670118.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Mental Health and Substance Use Disorder Expenditures in the US: Profiling Costs and Implications for Policy and Care OptimizationThis review synthesizes recent evidence on US mental health and substance use disorder expenditures, highlighting distribution by disorder, service type, and sociodemographic factors, and discusses research and policy directions to optimizeOct 15, 2026Oxytocin’s Role in Modulating Thyroid Function and Mental Health in Obesity: Insights from an 8-Week Clinical TrialAn 8-week trial reveals that intranasal oxytocin increases the free T3/free T4 ratio and correlates with improved mental health-related quality of life in adults with obesity, suggesting thyroid axis modulation as a potential mechanism forSep 16, 2026Receipt of Pharmacotherapy and Healthcare Utilization Among US Adults with Alcohol or Opioid Use Disorder: Insights from 2022-2023 National DataFew US adults with alcohol or opioid use disorder reported addiction pharmacotherapy use in 2022-2023. Pharmacotherapy receipt was linked to increased healthcare utilization, underscoring the need for early outpatient intervention strategieSep 3, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Long-Term Fatigue in Differentiated Thyroid Cancer Survivors: Early Predictors and the Non-Impact of Thyrotropin SuppressionA nationwide prospective study identifies early fatigue and poor mental health as key predictors of long-term fatigue in differentiated thyroid cancer patients, while thyrotropin suppression shows no association with fatigue.Aug 21, 2026
Real-Life Emotional Support, Social-Media-Based Emotional Support, and Loneliness Among US Adults: A Nationally Representative StudyThis study investigates how real-life versus social-media-based emotional support relates to loneliness among US adults, revealing stronger links between real-life support and reduced loneliness.Aug 17, 2026
GLP-1 Receptor Agonists May Reduce Hospital Admissions for Alcohol and Substance Use Disorders: Insights from a Swedish Nationwide StudyThis Swedish register-based study reveals that GLP-1 receptor agonists are associated with significantly reduced hospitalisations for alcohol and substance use disorders during treatment, with some lasting benefits after discontinuation ofAug 10, 2026